Therapeutic strategies in major depressive disorder resistant to treatment with serotonin uptake inhibitors. Pragmatic trial, parallel, randomized, blinded assessment [Estrategias terapeuticas en Trastorno Depresivo Mayor resistente a tratamiento con Inhibidores Selectivos de la Recaptacion de la Serotonina. Ensayo clínico pragmático, paralelo, aleatorizado con evaluacion enmascarada.]

Trial Profile

Therapeutic strategies in major depressive disorder resistant to treatment with serotonin uptake inhibitors. Pragmatic trial, parallel, randomized, blinded assessment [Estrategias terapeuticas en Trastorno Depresivo Mayor resistente a tratamiento con Inhibidores Selectivos de la Recaptacion de la Serotonina. Ensayo clínico pragmático, paralelo, aleatorizado con evaluacion enmascarada.]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs Lithium (Primary) ; Nortriptyline (Primary) ; Venlafaxine (Primary) ; Citalopram; Escitalopram; Fluoxetine; Fluvoxamine; Paroxetine; Sertraline
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top